Ichiro Nonin
Plus aucun poste en cours
Profil
Ichiro Nonin worked as a Director and Head of Financial Policy & IR Contact at VIA Holdings, Inc. from 2013 to 2014.
Prior to that, he worked as an Assistant Manager of Finance at Konaka Co., Ltd.
and as a Finance Manager at GE Capital Consumer Finance.
Anciens postes connus de Ichiro Nonin
Sociétés | Poste | Fin |
---|---|---|
KONAKA CO.,LTD. | Directeur Financier/CFO | - |
GE Capital Consumer Finance
GE Capital Consumer Finance Investment Banks/BrokersFinance Part of GE Aerospace, GE Capital Consumer Finance is a company that provides total healthcare solutions and develops products to improve people's lives. The company is based in Norwalk, CT. The company's cell therapy operating company, GC Labcell, has been developing its NK cell platform for over ten years and was the first to demonstrate the safety of fully allogeneic NK cells in patients. Labcell and its affiliate Cell occupy a state-of-the-art cell center with research labs, process development labs, and a GMP cell therapy manufacturing facility. GC Group, the parent company, aims to reduce greenhouse gas emissions and is Thailand's largest integrated petrochemical business. | Directeur Financier/CFO | - |
VIA HOLDINGS,INC. | Directeur Financier/CFO | 01/04/2014 |
Expériences
Fonctions occupées
Sociétés liées
Sociétés cotées | 2 |
---|---|
VIA HOLDINGS,INC. | Consumer Services |
KONAKA CO.,LTD. | Retail Trade |
Entreprise privées | 1 |
---|---|
GE Capital Consumer Finance
GE Capital Consumer Finance Investment Banks/BrokersFinance Part of GE Aerospace, GE Capital Consumer Finance is a company that provides total healthcare solutions and develops products to improve people's lives. The company is based in Norwalk, CT. The company's cell therapy operating company, GC Labcell, has been developing its NK cell platform for over ten years and was the first to demonstrate the safety of fully allogeneic NK cells in patients. Labcell and its affiliate Cell occupy a state-of-the-art cell center with research labs, process development labs, and a GMP cell therapy manufacturing facility. GC Group, the parent company, aims to reduce greenhouse gas emissions and is Thailand's largest integrated petrochemical business. | Finance |